Clinical Trials Directory

Trials / Completed

CompletedNCT00688142

Sleepiness and Brain Function: The Effect of Armodafinil in Shift Work Sleep Disorder

Magnetoencephalographic Imaging of Sleepiness: The Effect of Armodafinil in Shift Work Sleep Disorder

Status
Completed
Phase
Study type
Observational
Enrollment
24 (actual)
Sponsor
Henry Ford Health System · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The investigators hypothesize that in patients with shift work sleep disorder, armodafinil will specifically increase brain activity in the frontal cortex parallel with improvements in deficits of fundamental mechanisms of attention.

Detailed description

The current protocol will utilize a paradigm which is well suited to examine frontal attentional neuronal mechanisms by eliciting event related potential components known to reflect automatic stimulus detection as well as involuntary and voluntary attentional processes. The that end the proposed research has two specific aims. 1) Identify what areas of the frontal lobe and corresponding cognitive functions are impacted by excessive sleepiness in shift work sleep disorder and 2) identify specific brain areas affected by armodafinil and their role in improvement of fundamental attentional processes using a complex cognitive task targeting attentional control.

Conditions

Timeline

Start date
2008-02-01
Primary completion
2010-03-01
Completion
2010-03-01
First posted
2008-06-02
Last updated
2010-03-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00688142. Inclusion in this directory is not an endorsement.

Sleepiness and Brain Function: The Effect of Armodafinil in Shift Work Sleep Disorder (NCT00688142) · Clinical Trials Directory